Familial Blau syndrome:First molecularly confirmed report from India.

Indian J Ophthalmol

INSERM UMR1163, Laboratory of Neurogenetics and Neuroinflammation, Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France; Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.

Published: January 2019

Blau syndrome (BS) is a rare autoinflammatory disorder characterized by the clinical triad of arthritis, uveitis, and dermatitis due to heterozygous gain-of-function mutations in the NOD2 gene. BS can mimic juvenile idiopathic arthritis (JIA)-associated uveitis, rheumatoid arthritis, and ocular tuberculosis. We report a family comprising a mother and her two children, all presenting with uveitis and arthritis. A NOD2 mutation was confirmed in all the three patients - the first such molecularly proven case report of familial BS from India.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324106PMC
http://dx.doi.org/10.4103/ijo.IJO_671_18DOI Listing

Publication Analysis

Top Keywords

familial blau
4
blau syndromefirst
4
syndromefirst molecularly
4
molecularly confirmed
4
confirmed report
4
report india
4
india blau
4
blau syndrome
4
syndrome rare
4
rare autoinflammatory
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!